• GW 6471: Precision PPARα Antagonism for Metabolic Disease Mo

  2026-06-18

  Explore how GW 6471, a potent PPARα antagonist, enables high-fidelity metabolic disease modeling and advances cellular metabolism research. Discover new insights into assay optimization and mechanistic interrogation beyond existing studies.

• Human iPSC-Derived Sensory Neurons Enable HSV-1 Latency Mode

  2026-06-18

  This study establishes a scalable protocol to differentiate human inducible pluripotent stem cells into sensory neurons, creating a robust in vitro model for herpes simplex virus 1 (HSV-1) latent infection and reactivation. The findings address a major gap by providing a human neuron-based system to study HSV-1 latency, with important implications for virology and therapeutic research.

• PP 2 (AG 1879): Reliable Src Kinase Inhibition for Cell Assa

  2026-06-17

  This article examines the practical challenges of Src kinase inhibition in cell viability and signaling assays, highlighting how PP 2 (AG 1879) (SKU A8216) delivers reproducible, selective results. Scenario-driven Q&As address experimental design, protocol optimization, data interpretation, and vendor reliability, enabling researchers to optimize workflows and troubleshoot with confidence using validated data.

• Leptin (116-130), amide, mouse: New Horizons in Metabolic an

  2026-06-17

  Explore how Leptin (116-130), amide, mouse—a key adipocyte-derived hormone fragment—drives next-generation research in metabolic signaling, energy homeostasis, and immunometabolic disease. This article uniquely analyzes its integration with inflammasome and SIRT6-AMPK pathway insights, offering advanced assay strategies.

• TMEM16F in Kupffer Cells Restricts Listeria-Induced Necrotic

  2026-06-16

  This study uncovers the essential role of TMEM16F in Kupffer cells for protecting the liver from Listeria monocytogenes infection. The findings reveal that TMEM16F-mediated plasma membrane repair in liver macrophages limits necrotic cell death, inflammation, and metabolic dysfunction, advancing our understanding of host defense mechanisms against bacterial pathogens.

• BCL-XL Inhibitor A-1155463: Applied Protocols & Troubleshoot

  2026-06-16

  The selective BCL-XL inhibitor A-1155463 empowers researchers to dissect apoptosis mechanisms and tackle drug resistance in BCL-XL-dependent cancer models. This article delivers advanced workflow strategies, protocol enhancements, and troubleshooting guidance to maximize experimental impact using A-1155463.

• Angiotensin Peptides Potentiate SARS-CoV-2 Spike–AXL Binding

  2026-06-15

  The referenced study uncovers that naturally occurring angiotensin peptides, including truncated fragments, significantly enhance the binding of the SARS-CoV-2 spike protein to its host cell receptors, particularly AXL. These findings have important implications for both blood pressure regulation research and the understanding of viral pathogenesis, pointing to new mechanistic intersections within the renin-angiotensin system.

• Thermosensitive Hydrogel with MnO2 Nanozymes for Diabetic Wo

  2026-06-15

  This study presents a multifunctional, thermosensitive hydrogel that integrates hollow mesoporous MnO2 nanozymes and TGF-β1 for enhanced diabetic wound therapy. The hydrogel achieves controlled ROS scavenging and immune modulation, leading to accelerated wound healing and improved tissue regeneration.

• Fluorouracil in Solid Tumor Research: Protocols & Pitfalls

  2026-06-14

  Fluorouracil (Adrucil) stands out in solid tumor research by combining robust inhibition of DNA replication with flexibility across in vitro and in vivo workflows. This guide distills evidence-based protocols, troubleshooting strategies, and advanced use-cases to help researchers unlock its full potential in colon and breast cancer models.

• Deep Learning Enables Early Cardiotoxicity Detection in iPSC

  2026-06-13

  Grafton et al. (2021) introduce a scalable, high-content screening platform combining deep learning and iPSC-derived cardiomyocytes to detect cardiotoxic drug liabilities early in discovery. The approach improves predictive toxicology and enables more effective phenotypic screening of bioactive compounds.

• Thiamet G in O-GlcNAcase Inhibition: Beyond Neurodegeneratio

  2026-06-12

  Discover how Thiamet G, a potent O-GlcNAcase inhibitor, is advancing research on ferroptosis, trophoblast biology, and tauopathy. This article uniquely explores the intersection of O-GlcNAcylation modulation and disease modeling, highlighting novel translational opportunities.

• Phillygenin Mitigates Diabetic Nephropathy via Inflammatory

  2026-06-12

  This study demonstrates that phillygenin, a bioactive compound from Forsythia suspensa, reduces inflammation and apoptosis in diabetic nephropathy by targeting the TLR4/MyD88/NF-κB and PI3K/AKT/GSK3β signaling pathways. The findings offer mechanistic insight into phillygenin's therapeutic potential for diabetic kidney injury and support the use of fluorescence-based cell viability assays in mechanistic research.

• Polyphosphazene Nanoparticles: Spermine Crosslinking for Pro

  2026-06-11

  This study demonstrates how ionic polyphosphazene nanoparticles, cross-linked with spermine tetrahydrochloride, efficiently encapsulate proteins while preserving their activity and modulating cellular interactions. The findings advance nanoparticle engineering for therapeutic delivery, highlighting key differences between soluble and nanoparticulate formulations.

• SMYD2 Inhibition Attenuates Drug Resistance in Renal Cell Ca

  2026-06-11

  The referenced study identifies SMYD2 as a critical epigenetic regulator of multidrug resistance and tumor progression in clear cell renal cell carcinoma (ccRCC). By mechanistically linking SMYD2 to microRNA-125b and P-glycoprotein (P-gP) pathways, the research highlights new avenues for overcoming chemoresistance in aggressive renal cancers.

• SD 169 (indole-5-carboxamide): Mechanistic Precision in p38

  2026-06-10

  Explore how SD 169 (indole-5-carboxamide) uniquely enables precise modulation of p38 MAPK dephosphorylation, advancing type 1 diabetes and neuroregeneration research. This article offers a mechanistic analysis and practical assay insights not found in existing reviews.

15608 records 1/1041 page Next 12345 下5页 Last page